共 19 条
[1]
BRAWN PN, 1991, CANCER, V68, P1592, DOI 10.1002/1097-0142(19911001)68:7<1592::AID-CNCR2820680721>3.0.CO
[2]
2-M
[5]
Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1997, 277 (18)
:1456-1460
[6]
LONGITUDINAL EVALUATION OF PROSTATE-SPECIFIC ANTIGEN LEVELS IN MEN WITH AND WITHOUT PROSTATE DISEASE
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1992, 267 (16)
:2215-2220
[8]
PATHOLOGICAL AND CLINICAL FINDINGS TO PREDICT TUMOR EXTENT OF NONPALPABLE (STAGE-T1C) PROSTATE-CANCER
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1994, 271 (05)
:368-374
[9]
Cancer surveillance series: Interpreting trends in prostate cancer - Part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality
[J].
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE,
1999, 91 (12)
:1025-1032
[10]
A PROSPECTIVE EVALUATION OF PLASMA PROSTATE-SPECIFIC ANTIGEN FOR DETECTION OF PROSTATIC-CANCER
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1995, 273 (04)
:289-294